Brief overview of maternal triglycerides as a risk factor for pre-eclampsia

被引:145
作者
Ray, JG
Diamond, P
Singh, G
Bell, CM
机构
[1] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada
[2] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada
[3] Univ Toronto, Sch Med, Toronto, ON, Canada
关键词
hypertension; insulin resistance; lipid; metabolic syndrome; obesity; pre-eclampsia; pregnancy; triglyceride;
D O I
10.1111/j.1471-0528.2006.00889.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Features of the metabolic syndrome-maternal obesity, diabetes mellitus and chronic hypertension-are risk factors for pre-eclampsia. To determine the risk of pre-eclampsia in the presence of maternal hypertriglyceridemia, another major element of the metabolic syndrome. Two investigators independently searched PubMed and Embase databases from 1980 to December 2004 for relevant studies. The terms preeclampsia, eclampsia, pregnancy-induced hypertension or toxemia were combined with dyslipidemia, hyperlipidemia, hypertriglyceridemia, lipids, cholesterol, triglycerides (TG) or lipoprotein. We included case-control and cohort studies published in English that included at least 20 women with pre-eclampsia and that sampled serum or plasma TG at any time before, during or after pregnancy. Mean maternal TG concentrations were compared between cases and controls within each study. The odds ratio of pre-eclampsia was calculated by comparing the risk of pre-eclampsia among women in each higher TG concentration category with that in the lowest reference category. A total of 19 case-control and 3 prospective cohort studies were included. In 14 studies, the mean TG concentration was significantly higher among pre-eclamptic cases than among unaffected controls; in seven other studies, there was a nonsignificant trend in the same direction. The risk of pre-eclampsia typically doubled with each increasing TG category. In the four studies that adjusted for potential confounders, such as maternal age, parity and body mass index, there was about a four-fold higher risk of pre-eclampsia in the highest relative to the lowest TG category. There exists a consistent positive association between elevated maternal TG and the risk of pre-eclampsia. Given that maternal hypertriglyceridemia is a common feature of the metabolic syndrome, interventional studies are needed to determine whether pre-pregnancy weight reduction and dietary modification can lower the risk of pre-eclampsia.
引用
收藏
页码:379 / 386
页数:8
相关论文
共 50 条
[41]   Pre-eclampsia and long-term risk of arrhythmias [J].
Havers-Borgersen, Eva ;
Stahl, Anna ;
Johansen, Marianne ;
Jons, Christian ;
Kober, Lars ;
Fosbol, Emil L. .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 31 (13) :1621-1630
[42]   Pre-eclampsia and nasal CPAP: Part 1. Early intervention with nasal CPAP in pregnant women with risk-factors for pre-eclampsia: Preliminary findings [J].
Guillerninault, Christian ;
Palombini, Luciana ;
Poyares, Dalva ;
Takaoka, Shanon ;
Huynh, Nelly T. -L. ;
El-Sayed, Yasser .
SLEEP MEDICINE, 2007, 9 (01) :9-14
[43]   Feto-Maternal Microchimerism: The Pre-eclampsia Conundrum [J].
Hahn, Sinuhe ;
Hasler, Paul ;
Vokalova, Lenka ;
van Breda, Shane Vontelin ;
Than, Nandor Gabor ;
Hoesli, Irene Mathilde ;
Lapaire, Olav ;
Rossi, Simona W. .
FRONTIERS IN IMMUNOLOGY, 2019, 10
[44]   Association of Maternal and Perinatal Mortality with Hyperuricemia in Females Presenting With Pre-Eclampsia [J].
Naz, Tehmina ;
Khalid, Marina ;
Nawaz, Rizwana ;
Pervaiz, Muhammad Jawad ;
Arshad, Iqra .
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (04) :714-716
[45]   Maternal lipids in pre-eclampsia: innocent bystander or culprit? [J].
Barrett, Helen L. ;
Nitert, Marloes Dekker ;
McIntyre, H. David ;
Callaway, Leonie K. .
HYPERTENSION IN PREGNANCY, 2014, 33 (04) :508-523
[46]   Pre-eclampsia causes adverse maternal outcomes across the gestational spectrum [J].
Pettit, F. ;
Mangos, G. ;
Davis, G. ;
Henry, A. ;
Brown, M. A. .
PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2015, 5 (02) :198-204
[47]   Methylenetetrahydrofolate reductase polymorphisms are not a risk factor for pre-eclampsia/eclampsia in Australian women [J].
Kaiser, T ;
Brennecke, SP ;
Moses, EK .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2000, 50 (02) :100-102
[48]   Anesthetic management of parturients with pre-eclampsia and eclampsia [J].
Fetsch, N. I. ;
Bremerich, D. H. .
ANAESTHESIST, 2008, 57 (01) :87-101
[49]   Pre-eclampsia and the vascular endothelial growth factor: a new aspect [J].
Liberis, A. ;
Stanulov, G. ;
Ali, E. Chafouz ;
Hassan, A. ;
Pagalos, A. ;
Kontomanolis, E. N. .
CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2016, 43 (01) :9-13
[50]   Genetic polymorphisms of vascular endothelial growth factor in pre-eclampsia [J].
de Paula Cunha, Valquiria Maria ;
da Silva Grecco, Roseane Lopes ;
Paschoi, Marina Carvalho ;
da Silva, Sueli Riul ;
Ruiz, Mariangela Torreglosa ;
Spadotto Balarin, Marly Aparecida .
REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2011, 33 (07) :158-163